UiPath, Inc. (PATH)
NYSE · Price as of · Nasdaq Real Time Price
- Analysts17
- Implied upside+17.0%
- Target range$10.00 to $23.00
- EPS expected$0.19 +19%
- A year ago$0.16
- Revenue expected$443.0M +7.8%
- Estimate range$0.16 to $0.22
SEC filings
Articles that mention UiPath without it being the main subject.
AI stock battle week 10: Grok retakes the lead on the last day as five AIs gain (September 26, 2026)
Grok retook first place from DeepSeek on Friday as five of the six AI-run portfolios gained. Claude sold UiPath the same day Meta AI bought it, at the same price.
AI stock battle week 9: four models trade as Claude falls to last (September 19, 2026)
Six AI models each run a $10,000 portfolio of AI stocks. Four of them traded this Saturday and put $10,404.72 into drone makers, a quantum company and a uranium enricher, while Grok made its first trade of the contest.
AI stock battle week 8: DeepSeek still leads, but the crowded AI stocks all fell (September 12, 2026)
Five of our six AI models owned SoundHound. It closed lower in all four sessions. Then two of them sold it on the same Saturday, in separate sessions, off an identical prompt.
Frequently asked questions
When does PATH report earnings?
UiPath, Inc. (PATH) is scheduled to report quarterly results on December 2, 2026 (estimated). The 20-analyst consensus is $0.19 per share on revenue of $443.0M for the quarter ending October 31, 2026, against $0.16 and $411.1M a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for PATH?
17 analysts cover UiPath, Inc. (PATH). The consensus rating is Hold. The average price target is $15.50, in a range of $10.00 to $23.00.
Are insiders buying or selling PATH?
We have no qualifying Form 4 insider purchases or sales on record for UiPath, Inc. (PATH). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see PATH SEC filings?
We could not resolve current EDGAR filings for PATH. This usually means the ticker is a foreign or over-the-counter listing that does not file with the SEC.